Sennosides, USP 25 MG Oral Tablet — RxCUI 251292
RxNorm drug concept · Semantic clinical drug
RxCUI 251292
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
33 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI251292
Official nameSennosides, USP 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assennosides 25 MG Oral Tablet
FDA products mapped21
Package NDCs mapped33
Reported Medicaid activity (SDUD)27 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Senna: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
- How long does it take for senna to work?
- Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
- Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
🕸️ Concept Web — How Sennosides, USP 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sennosides, USP 25 MG Oral Tablet
RxCUI 251292 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sennosides, USP
36387IN
-
Sennosides, USP
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ex-Lax Maximum Relief Formula
217016BN
-
Ex-Lax Maximum Relief Formula
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sennosides, USP Oral Tablet
373859SCDF -
Sennosides, USP Oral Product
1159068SCDG -
Sennosides, USP Pill
1159069SCDG -
Sennosides, USP Oral Tablet [Ex-Lax Maximum Relief Formula]
368312SBDF -
Ex-Lax Maximum Relief Formula Oral Product
1171834SBDG -
Ex-Lax Maximum Relief Formula Pill
1171835SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Sennosides, USP Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sennosides, USP 25 MG
331426SCDC -
Sennosides, USP 25 MG Oral Tablet [Ex-Lax Maximum Relief Formula]
213073SBD -
Sennosides, USP 25 MG [Ex-Lax Maximum Relief Formula]
573008SBDC
-
Sennosides, USP 25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sennosides, USP 25 MG
SCDC · 331426 -
Sennosides, USP Oral Tablet
SCDF · 373859 -
Sennosides, USP Oral Product
SCDG · 1159068 -
Sennosides, USP Pill
SCDG · 1159069
Brand-Name Concepts
-
Sennosides, USP 25 MG Oral Tablet [Ex-Lax Maximum Relief Formula]
SBD · 213073 -
Sennosides, USP 25 MG [Ex-Lax Maximum Relief Formula]
SBDC · 573008 -
Sennosides, USP Oral Tablet [Ex-Lax Maximum Relief Formula]
SBDF · 368312 -
Ex-Lax Maximum Relief Formula Oral Product
SBDG · 1171834 -
Ex-Lax Maximum Relief Formula Pill
SBDG · 1171835 -
Ex-Lax Maximum Relief Formula
BN · 217016
📦 FDA Products & Package NDCs
21 products · 33 package NDCs
33 package NDCs map to RxCUI 251292 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00067-8142-01 | 2 BLISTER PACK in 1 CARTON (0067-8142-01) / 12 PILL in 1 BL... | EX-LAX MAXIMUM STRENGTH STIMULANT LAXATIVE | Haleon US Holdings LLC | 2017-07-01 |
| 00067-8142-02 | 4 BLISTER PACK in 1 CARTON (0067-8142-02) / 12 PILL in 1 BL... | EX-LAX MAXIMUM STRENGTH STIMULANT LAXATIVE | Haleon US Holdings LLC | 2017-07-01 |
| 00363-9978-24 | 2 BLISTER PACK in 1 CARTON (0363-9978-24) / 12 TABLET in 1... | Laxative | WALGREENS | 2023-04-15 |
| 00363-9978-48 | 4 BLISTER PACK in 1 CARTON (0363-9978-48) / 12 TABLET in 1... | Laxative | WALGREENS | 2023-04-15 |
| 00363-9978-90 | 90 TABLET in 1 BOTTLE (0363-9978-90) | Laxative | WALGREENS | 2023-04-15 |
| 11673-0995-48 | 48 TABLET in 1 BLISTER PACK (11673-995-48) | MAXIMUM STRENGTH LAXATIVE PILLS | TARGET CORPORATION | 2019-04-26 |
| 11822-0773-08 | 2 BLISTER PACK in 1 CARTON (11822-0773-8) / 12 TABLET, FILM... | Laxative | Rite Aid Corporation | 2024-11-26 |
| 11822-0773-09 | 8 BLISTER PACK in 1 CARTON (11822-0773-9) / 12 TABLET, FILM... | Laxative | Rite Aid Corporation | 2024-11-26 |
| 21130-0591-24 | 2 BLISTER PACK in 1 CARTON (21130-591-24) / 12 TABLET in 1... | Laxative | BETTER LIVING BRANDS LLC. | 2023-06-22 |
| 37808-0149-12 | 2 BLISTER PACK in 1 CARTON (37808-149-12) / 12 TABLET in 1... | HEB Maximum strength Laxative pills | H E B | 2018-04-02 |
| 37808-0149-27 | 6 BLISTER PACK in 1 CARTON (37808-149-27) / 15 TABLET in 1... | HEB Maximum strength Laxative pills | H E B | 2018-04-02 |
| 41226-0195-24 | 24 TABLET in 1 CARTON (41226-195-24) | MAXIMUM STRENGTH LAXATIVE | Kroger Company | 2020-06-01 |
| 41415-0114-24 | 2 BLISTER PACK in 1 CARTON (41415-114-24) / 12 TABLET in 1... | Publix Laxative Maximum Strength | PUBLIX SUPER MARKETS, INC | 2019-05-15 |
| 49483-0083-00 | 50000 TABLET, SUGAR COATED in 1 CARTON (49483-083-00) | LAX-TIME | TIME CAP LABORATORIES, INC | 2018-08-30 |
| 49483-0083-09 | 95 TABLET, SUGAR COATED in 1 BOTTLE (49483-083-09) | LAX-TIME | TIME CAP LABORATORIES, INC | 2021-12-31 |
| 50844-0773-08 | 2 BLISTER PACK in 1 CARTON (50844-773-08) / 12 TABLET, FILM... | Laxative | L.N.K. International, Inc. | 2022-06-18 |
| 55301-0773-08 | 2 BLISTER PACK in 1 CARTON (55301-773-08) / 12 TABLET, FILM... | Laxative | ARMY AND AIR FORCE EXCHANGE SERVICE | 2022-12-29 |
| 55319-0773-08 | 2 BLISTER PACK in 1 CARTON (55319-773-08) / 12 TABLET, FILM... | Laxative | Family Dollar Services Inc | 2024-02-09 |
| 55910-0454-08 | 2 BLISTER PACK in 1 CARTON (55910-454-08) / 12 TABLET, FILM... | Laxative | DOLGENCORP, LLC | 2023-02-23 |
| 55910-0454-22 | 4 BLISTER PACK in 1 CARTON (55910-454-22) / 12 TABLET, FILM... | Laxative | DOLGENCORP, LLC | 2023-02-23 |
| 63561-0186-02 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63561-0186-2) | Laxative | Granulation Technology, Inc. | 2025-07-29 |
| 63561-0186-09 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63561-0186-9) | Laxative | Granulation Technology, Inc. | 2025-06-11 |
| 69842-0195-09 | 90 TABLET, COATED in 1 BOTTLE, PLASTIC (69842-195-09) | MAXIMUM STRENGTH LAXATIVE | CVS HEALTH | 2020-12-01 |
| 69842-0195-24 | 24 TABLET, COATED in 1 BLISTER PACK (69842-195-24) | MAXIMUM STRENGTH LAXATIVE | CVS HEALTH | 2020-12-01 |
| 69842-0195-25 | 250 TABLET, COATED in 1 BOTTLE, PLASTIC (69842-195-25) | MAXIMUM STRENGTH LAXATIVE | CVS HEALTH | 2020-12-01 |
| 70000-0077-01 | 24 TABLET in 1 BLISTER PACK (70000-0077-1) | MAXIMUM STRENGTH LAXATIVE | CARDINAL HEALTH | 2021-01-11 |
| 72090-0016-01 | 100 TABLET in 1 BOTTLE (72090-016-01) | Maximum Strength Senna Laxative | Pioneer Life Sciences, LLC | 2025-03-06 |
| 76162-0773-08 | 2 BLISTER PACK in 1 CARTON (76162-773-08) / 12 TABLET, FILM... | Laxative | TOPCO ASSOCIATES LLC | 2022-06-18 |
| 79481-7730-02 | 4 BLISTER PACK in 1 CARTON (79481-7730-2) / 12 TABLET, FILM... | Laxative | Meijer Distribution, Inc. | 2024-08-30 |
| 79481-7730-08 | 2 BLISTER PACK in 1 CARTON (79481-7730-8) / 12 TABLET, FILM... | Laxative | Meijer Distribution, Inc. | 2024-08-30 |
| 79903-0096-08 | 1 BOTTLE, PLASTIC in 1 CARTON (79903-096-08) / 24 TABLET, F... | Laxative | WALMART INC. | 2021-12-21 |
| 79903-0096-52 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (79903-096-52) | Laxative | WALMART INC. | 2021-12-21 |
| 84324-0033-01 | 60 TABLET in 1 BOTTLE (84324-033-01) | Maximum Strength Senna Laxative | NUVICARE LLC | 2026-01-22 |
Observed labelers:
CVS HEALTH (3) ·
WALGREENS (3) ·
DOLGENCORP, LLC (2) ·
Granulation Technology, Inc. (2) ·
H E B (2) ·
Haleon US Holdings LLC (2)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.